Published in Am J Gastroenterol on June 01, 2012
Quality of life after surgical treatment of early Barrett's cancer: a prospective comparison of the Ivor-Lewis resection versus the modified Merendino resection. World J Surg (2014) 2.65
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc (2013) 0.93
Indications and Techniques for Endoscopic Submucosal Dissection. Am J Gastroenterol (2015) 0.88
Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. Surg Endosc (2013) 0.87
A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Gastrointest Endosc (2013) 0.86
Evidence-based endoscopic management of Barrett's esophagus. Gastroenterol Rep (Oxf) (2014) 0.84
Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) (2013) 0.83
Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc (2014) 0.80
Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2014) 0.80
Endoscopic options for treatment of dysplasia in Barrett's esophagus. World J Gastrointest Endosc (2015) 0.80
Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer. Surg Endosc (2016) 0.79
Surgical Therapy of Early Carcinoma of the Esophagus. Viszeralmedizin (2015) 0.77
Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Rep (Oxf) (2015) 0.77
Management of early-stage esophageal neoplasia (MESEN) consensus. World J Surg (2014) 0.77
Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg (2017) 0.77
How to establish endoscopic submucosal dissection in Western countries. World J Gastroenterol (2015) 0.76
Endoscopic methods in the treatment of early-stage esophageal cancer. Wideochir Inne Tech Maloinwazyjne (2014) 0.76
Endoscopic assessment and management of early esophageal adenocarcinoma. World J Gastrointest Oncol (2014) 0.76
Endoscopic mucosal resection or ablation for Barrett's esophagus containing high grade dysplasia: agreement strongest among expert gastroenterologists. Endosc Int Open (2014) 0.75
Barrett's esophagus: lessons from recent clinical trials. Ann Gastroenterol (2016) 0.75
A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes. Clin Gastroenterol Hepatol (2015) 0.75
Please provide us with a reasonable definition for curative R0 resection in Barrett's esophagus neoplasia; which one should we choose? Endosc Int Open (2015) 0.75
Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc (2016) 0.75
How common are lymph node metastases in patients with Barrett's esophagus complicated by high-grade dysplasia or intramucosal cancer? Gastroenterology (2012) 0.75
Managing Barrett's esophagus with radiofrequency ablation. Gastroenterol Rep (Oxf) (2013) 0.75
Barrett's oesophagus: Current controversies. World J Gastroenterol (2017) 0.75
Tumor location is a risk factor for lymph node metastasis in superficial Barrett's adenocarcinoma. Endosc Int Open (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg (2011) 4.80
Selective therapeutic approach to cancer of the lower esophagus and cardia. J Thorac Cardiovasc Surg (1988) 3.13
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol (2000) 2.58
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg (2005) 2.28
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg (1998) 2.25
The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg (2011) 2.13
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut (2010) 2.01
Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol (1993) 1.95
Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg (2001) 1.93
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (1999) 1.90
Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology (2009) 1.88
The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol (2008) 1.85
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch (2005) 1.74
Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Gastrointest Endosc (2009) 1.73
Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg (2006) 1.71
Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Ann Surg (2007) 1.70
High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg (2002) 1.70
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg (2008) 1.67
High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy (2006) 1.66
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol (2008) 1.62
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61
Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy (2004) 1.58
Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg (1992) 1.54
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol (2008) 1.46
Surgical therapy in Barrett's esophagus. Ann Surg (1990) 1.43
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg (2000) 1.41
Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc (2004) 1.40
The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg (1996) 1.39
Dysplasia in Barrett's esophagus: limitations of current management strategies. Am J Gastroenterol (2005) 1.37
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol (2005) 1.36
Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg (2010) 1.24
Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc (2001) 1.21
Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol (2007) 1.20
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol (1995) 1.17
Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg (2005) 1.17
Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer. Endoscopy (2010) 1.14
Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg (1991) 1.13
Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg (1994) 1.11
Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg (2002) 1.11
Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2009) 1.10
Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia. Gastrointest Endosc (1994) 1.10
Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer (2000) 1.08
Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc (2001) 1.07
Adenocarcinoma in columnar-lined Barrett's esophagus. Analysis of 13 esophagectomies. Am J Surg (1985) 1.07
A laparoscopy-assisted surgical approach to esophageal carcinoma. J Surg Res (2004) 1.05
Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg (2006) 1.05
The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer (1994) 1.05
Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery (2000) 1.05
Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg (2005) 1.00
Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol (2010) 1.00
Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer (2008) 0.99
Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg (2007) 0.99
Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett's dysplasia. Clin Gastroenterol Hepatol (2010) 0.95
Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol (2005) 0.94
Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus. ANZ J Surg (2003) 0.93
Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg (2010) 0.90
Early Barrett's carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch (2010) 0.90
Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut (2003) 0.89
Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus (1997) 0.88
High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol (2006) 0.87
Exclusive radical surgery for esophageal adenocarcinoma. Cancer (2001) 0.87
Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. Am J Surg (1997) 0.86
Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus. Mod Pathol (2008) 0.84
Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol (2011) 0.82
[Spontaneous disappearance of pulmonary metastasis secondary to renal cell carcinoma after nephrectomy. Presentation of a case and review of the literature]. Actas Urol Esp (1992) 0.81
Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J Surg Oncol (2009) 0.80
Comparison of oncological outcomes after laparoscopic transhiatal and open esophagectomy for T1 esophageal adenocarcinoma. Surg Endosc (2008) 0.79
Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view. J Am Coll Surg (2003) 0.78
Transhiatal oesophagectomy: treatment of choice for high-grade dysplasia. Eur J Cardiothorac Surg (2009) 0.78
Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma. Am J Surg Pathol (2011) 0.77
Superficial adenocarcinoma of the oesophagus arising in Barrett's mucosa with dysplasia: a clinico-pathological study of 12 patients. Histopathology (1990) 0.77
Commentary: Esophageal carcinoma confined to the wall--the need for immediate definitive therapy. J Thorac Cardiovasc Surg (1999) 0.76
How radical should surgery be for early esophageal cancer? World J Surg (2011) 0.76
Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol (2009) 3.65
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut (2012) 2.00
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci (2009) 1.91
Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol (2008) 1.53
Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol (2011) 1.50
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology (2002) 1.46
Sorafenib for treatment of hepatocellular carcinoma: a systematic review. Dig Dis Sci (2012) 1.45
Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. Dis Esophagus (2008) 1.07
Fatal hyperammonemic encephalopathy after gastric bypass surgery. Am J Med (2008) 1.03
Pneumatic dilation and laparoscopic Heller's myotomy equally effective for achalasia. N Engl J Med (2011) 1.01
A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci (2010) 0.99
Managing Barrett's oesophagus. BMJ (2003) 0.98
Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection. Am J Gastroenterol (2004) 0.96
Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett (2008) 0.96
Integrated approach to treatment of children and adults with eosinophilic esophagitis. Gastrointest Endosc Clin N Am (2008) 0.93
High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol (2006) 0.87
Carcinogenesis at the gastroesophageal junction: free radicals at the frontier. Gastroenterology (2002) 0.86
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol (2012) 0.85
Stem cells in Barrett's esophagus: HALOs or horns? Gastrointest Endosc (2008) 0.84
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers. Am J Gastroenterol (2003) 0.82
Development and characterization of a surgical mouse model of reflux esophagitis and Barrett's esophagus. J Gastrointest Surg (2013) 0.81
Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study. Am J Gastroenterol (2007) 0.81
Irreversible ototoxicity associated with difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (2004) 0.81
Upper gastrointestinal bleeding in a patient with AIDS. Nat Clin Pract Gastroenterol Hepatol (2006) 0.81
Surgery for gastroesophageal reflux disease: esophageal impedance to progress? Clin Gastroenterol Hepatol (2009) 0.80
Barrett's Esophagus without dysplasia: wait or ablate? Dig Dis Sci (2011) 0.77
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus. Am J Physiol Gastrointest Liver Physiol (2007) 0.77
Laryngopharyngeal reflux: a cause of faulty phonation or a faulted, phony diagnosis? Clin Gastroenterol Hepatol (2006) 0.77
Biomarkers and photodynamic therapy for Barrett's esophagus: time to FISH or cut bait? Gastroenterology (2008) 0.77
Barrett's esophagus: is the goblet half empty? Clin Gastroenterol Hepatol (2012) 0.76
Buried (but not dead) Barrett's metaplasia: tales from the crypts. Gastrointest Endosc (2012) 0.75
Esophageal human β-defensin expression in eosinophilic esophagitis. Pediatr Res (2013) 0.75
Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name? Gut (2016) 0.75